NASDAQ: MRVI - Maravai LifeSciences Holdings, Inc.

Yield per half year: -47.79%
Sector: Healthcare

Maravai LifeSciences Holdings, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
7.19 48.72 -85.24% 10.97 -34.42%
P/S 3.03 33.75 -91.02%
P/BV 1.11 4.82 -76.98%
P/FCF 21.92 61 -64.06%
Ev/Ebitda 20.45 -22.17 -192.26%
Ev/S 3.16 22.56 -86.01%
Ev/FCF 15.03 68.75 -78.14%
E/P -0.0895 0.0178 -603.55%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
15.43 4.98 210.03% 90.09 -82.87%
ROE -28.56 9.61 -397.15%
ROA -8 0.3443 -2424.47%
ROIC 30.72 7.63 302.39%
ROS -41.19 -25.17 63.65%
ROCE -0.5313 15.35 -103.46%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
11.92 -3.68 -424.36% 5.33 +123.73%
Nеt Debt/Ebitda 0.8076 -3.44 -123.5%
Debt/Ratio 0.3574 0.1985 80.05%
Debt/Equity 0.6269 1.66 -62.28%
Debt/Net Income -4.47 10.32 -143.26%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 69.89 43.56 60.43%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
101.92 -56.89 -279.15%
Growth impulse Ebitda in 5 years 1368.88 -54.68 -2603.44%
Growth impulse Net Income in 5 years 2189.02 -58.33 -3852.82%
Growth impulse FCF in 5 years 766.73 -49.48 -1649.58%
Growth impulse EPS in 5 years 1442.37 -32.41 -4550.39%
IP Score
5.57/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription